doc. MUDr. Igor Kiss, Ph.D., MBA
Department head, Comprehensive Cancer Care Department
Total number of publications: 222
2018
-
Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection
CANCER GENOMICS & PROTEOMICS, year: 2018, volume: 15, edition: 4, DOI
2017
-
MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX
Oncology letters, year: 2017, volume: 14, edition: 1, DOI
-
MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9
Oncogenesis, year: 2017, volume: 6, edition: 11, DOI
-
Outcomes of Patients With Long-Term Treatment Response to Vascular Endothelial Growth Factor-Targeted Therapy for Metastatic Renal Cell Cancer
CLINICAL GENITOURINARY CANCER, year: 2017, volume: 15, edition: 6, DOI
-
Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry
Targeted Oncology, year: 2017, volume: 12, edition: 1, DOI
-
Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry
BMC Cancer, year: 2017, volume: 17, edition: 880, DOI
2016
-
Aberrant methylation of tumour suppressor genes WT1, GATA5 and PAX5 in hepatocellular carcinoma.
Clin Chem Lab Med, year: 2016, volume: 54(12), edition: Dec 1, DOI
-
Anémie u onkologických pacientů
Onkologie v klinické praxi : standardní přístupy v diagnostice a léčbě vybraných zhoubných nádorů, edition: 2. vydání, year: 2016, number of pages: 4 s.
-
BATON-CRC: a phase II randomized trial comparing tivozanib plus mFOLFOX6 with bevacizumab plus mFOLFOX6 in stage IV metastatic colorectal cancer
Journal of Experimental and Clinical Cancer Research, year: 2016, volume: 22/20, edition: Oct 15, DOI
-
Dlouhodobá parciální remise metastatického inflamatorního myofibroblastického tumoru pankreatu po chemoterapii - kazuistika pacienta
Year: 2016